EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeit

The effect of gonadotropin-releasing hormone analog treatment on the endocrine system in central precocious puberty patients: a meta-analysis

Na Guo, Fei Zhou, Xiaolan Jiang, Linlin Yang, Huijuan Ma

Journal of Pediatric Endocrinology and Metabolism · 25.03.2024 · 37 (3) · 197-208

DOI: 10.1515/jpem-2023-0480 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, online erschienen am 19.01.2024. Verfasst von Na Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Hebei North University, Zhangjiakou, Hebei, P.R. China. Hauptthemen laut MEDLINE: Puberty, Precocious. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives Gonadotropin-releasing hormone (GnRHa) is the first choice for the treatment of patients with central precocious puberty (CPP). However, the effects of GnRHa on the endocrine system of CPP patients, including insulin sensitivity, lipid level, thyroid function, bone mineral density (BMD), and testosterone (T) level, are currently contradictory. Therefore, the long-term safety of GnRHa therapy remains controversial. Content A systematic literature search was performed using PubMed, Embase, Cochrane Library, and CNKI databases. The changes in HOMA-IR, TG, LDL-C, HDL-C, TSH, FT3, FT4, T, and BMD in CPP patients before and after GnRHa treatment were compared by meta-analysis. As the heterogeneity between studies, we estimated standard deviation mean differences (SMDs) and 95 % confidence intervals (CIs) using a random-effects model. Egger’s test was used to assess publication bias. Summary A total of 22 studies were included in our meta-analysis. Compared with before GnRHa treatment, there were no statistically significant differences in endocrine indicators including HOMA-IR, TG, LDL-C, HDL-C, TSH, FT4, FT3, T, and BMD of CPP patients treated with GnRHa. Outlook Treatment with GnRHa for central precocious puberty will not increase the adverse effect on the endocrine system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Puberty, PrecociousHumansCholesterol, LDLGonadotropin-Releasing HormoneBody HeightEndocrine SystemThyrotropin

Stichwörter der Autor:innen

GnRHacentral precocious pubertyinsulin resistancemeta-analysis

Substanzen

Cholesterol, LDLGonadotropin-Releasing HormoneThyrotropin

Autor:innen und Institutionen

  • Graduate School of Hebei North University, Zhangjiakou, Hebei, P.R. China.
  • Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang, Hebei, P.R. China.
  • Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, P.R. China.
  • Data Center, The First Hospital of Hebei Medical University, Hebei, 050031, P.R. China.
  • Department of Endocrinology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.

Zitieren

APA

Guo, N., Zhou, F., Jiang, X., Yang, L., & Ma, H. (2024). The effect of gonadotropin-releasing hormone analog treatment on the endocrine system in central precocious puberty patients: a meta-analysis. Journal of Pediatric Endocrinology and Metabolism, 37(3), 197-208. https://doi.org/10.1515/jpem-2023-0480

Vancouver

Guo N, Zhou F, Jiang X, Yang L, Ma H. The effect of gonadotropin-releasing hormone analog treatment on the endocrine system in central precocious puberty patients: a meta-analysis. Journal of Pediatric Endocrinology and Metabolism. 2024;37(3):197-208. doi:10.1515/jpem-2023-0480

BibTeX
@article{Guo2024,
  author = {Guo, Na and Zhou, Fei and Jiang, Xiaolan and Yang, Linlin and Ma, Huijuan},
  title = {The effect of gonadotropin-releasing hormone analog treatment on the endocrine system in central precocious puberty patients: a meta-analysis},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2024},
  volume = {37},
  number = {3},
  pages = {197--208},
  doi = {10.1515/jpem-2023-0480}
}
Kostenlos starten →